The FDA approved a drug to treat children with schizophrenia and bipolar disorder Wednesday.
The drug Risperdal is now approved to treat children with the two psychiatric conditions.
The drug is already approved to treat adults with schizophrenia and children with irritability related to autism.
This is the first drug approved to treat the conditions in the pediatric population.
Before the approval, doctors had prescribed drugs off-label.
Officials note the drug does have side effects, including an increased risk for diabetes and obesity as well as drowsiness, fatigue and rash.